Tumour glycolysis: The many faces of HIF

Journal of Theoretical Biology

Volumn 254, Issue 2, 2008, Pages 508-513

  Kelly, Catherine ^a   Smallbone, Kieran ^b   Brady, Michael ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Molecular imaging

Indexed keywords

FLUORODEOXYGLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

CANCER; CYTOLOGY; KINETICS; METABOLISM; MUTATION; TOMOGRAPHY; TUMOR;

ARTICLE; CONCEPTUAL FRAMEWORK; GLYCOLYSIS; HYPOXIA; METABOLIC REGULATION; MICROENVIRONMENT; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; VASCULAR TUMOR;

ANIMALS; CELL HYPOXIA; COMPUTER SIMULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; SIGNAL TRANSDUCTION;

EID: 50149105406     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2008.05.025     Document Type: Article

References (26)

1. Baxter L.T., and Jain R.K. Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. Microvasc. Res. 41 (1991) 5
2. Brock C.S., Young H., O'Reilly S.M., et al. Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas. Br. J. Cancer 82 (2000) 608
3. Burgman P., ODonoghue J.A., and Humm J.L. Hypoxia-induced increase in FDG uptake in MCF7 cells. J. Nucl. Med. 42 (2001) 170
4. Casciari J.J., Sotirchos S.V., and Sutherland R.M. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. Cancer Res. 48 (1988) 3905
5. Cher L.M., Murone C., Lawrentschuk N., Ramdave S., Papenfuss A., Hannah A., OḰeefe G.J., Sachinidis J.I., Berlangieri S.U., Fabinyi G., and Scott A.M. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J. Nucl. Med. 47 (2006) 410
6. Cherk M.H., Foo S.S., Poon A.M.T., Knight S.R., Murone C., Papenfuss A.T., Sachinidis J.I., Saunder T.H.C., O'Keefe G.J., and Scott A.M. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET. J. Nucl. Med. 47 (2006) 1921
7. Clavo A.C., Brown R.S., and Wahl R.L. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J. Nucl. Med. 36 (1995) 1625
8. Czernin J., and Phelps M.E. Positron emission tomography scanning: current and future applications. Annu. Rev. Med. 53 (2002) 89
9. Dasu A., Toma-Dasu I., and Karlsson M. Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia. Phys. Med. Biol. 48 (2003) 2829
10. Faivre S., Kroemer G., and Raymond E. Molecular events resulting in the activation of the PI3K/AKT/mTOR pathway in human tumours. Nat. Rev. Drug Discov. 5 (2006) 671
11. Gambhir S.S. Molecular imaging of cancer with positron emission tomography. Nat. Rev. Cancer 2 (2002) 683
12. Gingras A.C., Raught B., and Sonenberg N. Control of translation by the target of rapamycin proteins. Prog. Mol. Subcell. Biol. 27 (2001) 143
13. Jewell U.R., Kvietikova I., Scheid A., Bauer C., Wenger R.H., and Gassmann M. Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J. 15 (2001) 1312
14. Kelly C.J., and Brady J.M. A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data. Phys. Med. Biol. 51 (2006) 5859
15. Muzi M., Freeman S.D., Burrows R.C., et al. Kinetic characterization of hexokinase isoenzymes from glioma cells: implications for FDG imaging of human brain tumors. Nucl. Med. Biol. 28 (2001) 107
16. Padera T.P., Kadambi A., di Tomaso E., et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296 (2002) 1883
17. Peterson R.T., Beal P.A., Comb M.J., and Schreiber S.L. FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J. Biol. Chem. 10 (2000) 7416
18. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., and Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (18F) 2-fluoro-2-deoxy-D-glucose: validation of method. Ann. Neurol. 6 (1979) 371
19. Saitoh M., Pullen N., Brennan P., Cantrell D., Dennis P.B., and Thomas G. Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J. Biol. Chem. 277 (2002) 20104
20. Semenza G.L., Roth P.H., Fang H.M., and Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269 (1994) 23757
21. Smallbone K., Gavaghan D.J., Gatenby R.A., and Maini P.K. The role of acidity in solid tumour growth and invasion. J. Theor. Biol. 21 (2005) 476
22. Smallbone K., Gavaghan D.J., Maini P.K., and Brady J.M. Quiescence as a mechanism for cyclical hypoxia and acidosis. J. Math. Biol. 55 (2007) 767
23. Thomlinson R.H., and Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9 (1955) 539
24. Venkatasubramanian R., Henson M.A., and Forbes N.S. Incorporating energy metabolism into a growth model of multicellular tumor spheroids. J. Theor. Biol. 242 (2006) 440
25. Wang G.L., and Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268 (1993) 21513
26. Zeidman I., Copeland B.E., and Warren S. Experimental studies on the spread of cancer in the lymphatic system. II. Absence of a lymphatic supply in carcinoma. Cancer 8 (1955) 123